Loading data
ICCCNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 27.64 m USD | 26.49 m USD | 17.47 m USD | 18.57 m USD | 19.24 m USD |
| Cost of revenue | 16.2 m USD | 18.55 m USD | 13.6 m USD | 10.92 m USD | 10.59 m USD |
| Gross profit | 11.45 m USD | 7.94 m USD | 3.87 m USD | 7.65 m USD | 8.66 m USD |
| Research and development expense | 3.04 m USD | 3.9 m USD | 4.39 m USD | 4.49 m USD | 4.17 m USD |
| Operating profit | 1.65 m USD | -1.64 m USD | -5.75 m USD | -2.3 m USD | 257.39 k USD |
| Interest expense | — | — | 475.6 k USD | 348.54 k USD | 314.36 k USD |
| Profit before tax | -1.03 m USD | -2.15 m USD | -5.77 m USD | -2.49 m USD | -69.13 k USD |
| Income tax expense | 11.57 k USD | 10.06 k USD | 4.63 k USD | 7.67 k USD | 9.17 k USD |
| Net income (reported basis) | -1.04 m USD | -2.16 m USD | -5.78 m USD | -2.49 m USD | -78.29 k USD |
| Basic earnings per share | -0.12 USD/share | -0.26 USD/share | -0.75 USD/share | -0.32 USD/share | -0.01 USD/share |
| Diluted earnings per share | -0.12 USD/share | -0.26 USD/share | -0.75 USD/share | -0.32 USD/share | -0.01 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.